In fact, prior to the advent of ADT with GnRHa, estrogen was used as a treatment for PCa, inhibiting testicular androgen production and release via a negative feedback loop to inhibit the release of hypothalamic LHRH and pituitary luteinizing hormone (LH) [30]. The gene discussed is GNRH1; the disease is posterior cortical atrophy.